Stage IIIC2 Uterine Corpus Cancer
2 clinical trials · Condition
◉ Watch Stage IIIC2 Uterine Corpus Cancer
| Record | Firm | Date |
|---|---|---|
| Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer (NCT02112552) | Albert Einstein College of Medicine | 2014-04-10 |
| Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (NCT00729586) | National Cancer Institute (NCI) | 2008-09-01 |
Track Stage IIIC2 Uterine Corpus Cancer automatically
Every clearance here is in the API, with alerts when new ones post.